FDA Approved Products

1,302 products with lifecycle intelligence, competitive pressure scores, and patent timelines.

Type:AllNDABLAANDA
Lifecycle:GrowthPeakLOE ApproachingPost-LOELaunchPre-Launch
Sort:Approval DateNameCompetitive Pressure↓
Active:Lifecycle: PeakClear all
EXSERVAN
riluzole
Peak
ORAL · FILM
amyotrophic lateral sclerosis (ALS) ( )
2019
SMNDA
30/100
FENTANYL CITRATE
fentanyl citrate
Peak
INTRAVENOUS · SOLUTION
2023
NDA
30/100
FERRIPROX
deferiprone
Peak
Chiesi
ORAL · TABLET
2011
NDA
30/100
FIRAZYR
icatibant acetate
Peak
Takeda
SUBCUTANEOUS · INJECTABLE
acute attacks of hereditary angioedema (HAE) in adults 18 years of ageolder
2011
NDA
30/100
FLONASE ALLERGY RELIEF
fluticasone propionate
Peak
GSK
NASAL · SPRAY, METERED
2014
NDA
30/100
FLOWTUSS
guaifenesin; hydrocodone bitartrate
Peak
Molecular Devices
ORAL · SOLUTION
2015
NDA
30/100
FLUORODOPA F18
fluorodopa f18
Peak
Medica Corp
INTRAVENOUS · SOLUTION
2019
NDA
30/100
FLUOXETINE HYDROCHLORIDE
fluoxetine hcl
Peak
ORAL · TABLET
2011
NDA
30/100
FOSAPREPITANT DIMEGLUMINE
fosaprepitant
Peak
Teva
INTRAVENOUS · POWDER
delayed nauseavomiting associated with initial+3
2019
NDA
30/100
FULVESTRANT
fulvestrant
Peak
Viatris (2)
INTRAMUSCULAR · SOLUTION
2019
NDA
30/100
GALLIUM GA 68 EDOTREOTIDE
edotreotide gallium ga-68
Peak
Imagin Medical
INTRAVENOUS · SOLUTION
2019
PeptideNDA
30/100
GALLIUM GA 68 GOZETOTIDE
gallium ga-68 gozetotide
Peak
Angeles Therapeutics
INTRAVENOUS · SOLUTION
2020
PeptideNDA
30/100
GALLIUM GA 68 GOZETOTIDE
gallium ga-68 gozetotide
Peak
Francis Medical
INTRAVENOUS · SOLUTION
2020
PeptideNDA
30/100
GAVRETO
pralsetinib
Peak
Blueprint Medicines
ORAL · CAPSULE
2020
SMNDA
30/100
GELNIQUE 3%
oxybutynin
Peak
AbbVie
TRANSDERMAL · GEL, METERED
2011
NDA
30/100
GEMCITABINE HYDROCHLORIDE
gemcitabine
Peak
Pfizer
INJECTION · INJECTABLE
breast cancerlung cancer
2011
NDA
30/100
GEMCITABINE HYDROCHLORIDE
gemcitabine
Peak
Accord Biopharma
INTRAVENOUS · SOLUTION
breast cancerlung cancer
2017
NDA
30/100
GLEOLAN
aminolevulinic acid hydrochloride
Peak
ORAL · FOR SOLUTION
glioma (suspected World Health Organization Grades IIIIV on preoperative imaging)
2017
NDA
30/100
GLUCAGON
glucagon
Peak
Fresenius Kabi
INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS · POWDER
2015
NDA
30/100
GLYCOPYRROLATE
glycopyrrolate
Peak
Fresenius Kabi
INTRAMUSCULAR, INTRAVENOUS · SOLUTION
2022
NDA
30/100
GLYRX-PF
glycopyrrolate
Peak
INTRAMUSCULAR, INTRAVENOUS · SOLUTION
2018
NDA
30/100
HELIUM, USP
helium
Peak
INHALATION · GAS
2018
NDA
30/100
HELIUM, USP
helium
Peak
INHALATION · GAS
2014
NDA
30/100
HELIUM, USP
helium
Peak
INHALATION · GAS
2013
NDA
30/100
← PreviousPage 6 of 55Next →